Patients with severe symptomatic aortic stenosis have a poor prognosis with medical
management alone, and surgical aortic valve replacement can improve symptoms and …

Traditional surgical aortic valve replacement is the gold standard in treating patients with
critical aortic stenosis, which allows to improve the quality and duration of life of the patients …

The first human transcatheter aortic valve implantation (TAVI) in 2002, and several
subsequent single-center series, showed the feasibility of this new approach for the …

Aortic valve stenosis leads to dyspnoea, syncope, heart failure and limited life expectancy, 5-
year survival is only 15–50%[1]. For highrisk patients, transcatheter aortic valve implantation …

Transcatheter aortic valve implantation (TAVI) has developed rapidly since the first-in-man
implantation performed by Alain Cribier in Rouen in 2002. This new approach for the …

POL-TAVI – Polish Registry of Transcatheter Aortic Valve Implantation – simple tool, great
value, rationale and design Page 1 Kardiochirurgia i Torakochirurgia Polska 2016; 13 (4) 309 …

Background Transcatheter aortic valve implantation (TAVI) is a new treatment option for
patients with severe symptomatic aortic stenosis. Despite a lack of scientific evidence for a …

Aortic stenosis is the most common valvular heart disease in Western industrial countries
(including Switzerland) with a prevalence of about 5% in the population aged 75 and over. If …

Transcatheter aortic valve implantation (TAVI) is assuming a major role in the routine
management of patients with aortic stenosis. Surgical aortic valve replacement is generally …

The development of transcatheter aortic valve implantation (TAVI) by our group has been a
20-year odyssey. In 1993, postmortem studies validated the concept of intravalvular stenting …